title: Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy.
authors.affiliation: Transplantation Unit, Hospital Clinico Universitario, 15706 Santiago de Compostela, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Varo
authors.forename: E
authors.initials: E
authors.lastname: Padin
authors.forename: E
authors.initials: E
authors.lastname: Otero
authors.forename: S
authors.initials: S
authors.lastname: Tomé
authors.forename: J F
authors.initials: JF
authors.lastname: Castroagudin
authors.forename: M
authors.initials: M
authors.lastname: Delgado
authors.forename: R
authors.initials: R
authors.lastname: Conde
authors.forename: F R
authors.initials: FR
authors.lastname: Segade
authors.forename: C
authors.initials: C
authors.lastname: Mella
authors.forename: A
authors.initials: A
authors.lastname: González-Quintela
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001835:Body Weight; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007677:Kidney Function Tests; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors; D016559:Tacrolimus / Q000009:adverse effects*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus